As of 2025-03-15, the Relative Valuation of Revolution Medicines Inc (RVMD) is (87.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 39.03 USD, the upside of Revolution Medicines Inc based on Relative Valuation is -323.3%.
The range of the Relative Valuation is (70.17) - (98.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 36.3x | 29.0x |
| Forward P/E multiples | 19.4x - 30.6x | 25.0x |
| Fair Price | (70.17) - (98.71) | (87.15) |
| Upside | -279.8% - -352.9% | -323.3% |
| Date | P/E |
| 2025-03-10 | -11.41 |
| 2025-03-07 | -12.15 |
| 2025-03-06 | -12.15 |
| 2025-03-05 | -12.27 |
| 2025-03-04 | -11.76 |
| 2025-03-03 | -11.88 |
| 2025-02-28 | -12.62 |
| 2025-02-27 | -12.11 |
| 2025-02-26 | -12.55 |
| 2025-02-25 | -12.81 |
| 2025-02-24 | -12.77 |
| 2025-02-21 | -12.81 |
| 2025-02-20 | -13.09 |
| 2025-02-19 | -13.12 |
| 2025-02-18 | -12.85 |
| 2025-02-14 | -12.60 |
| 2025-02-13 | -12.80 |
| 2025-02-12 | -13.01 |
| 2025-02-11 | -12.84 |
| 2025-02-10 | -13.03 |
| 2025-02-07 | -13.07 |
| 2025-02-06 | -13.50 |
| 2025-02-05 | -13.71 |
| 2025-02-04 | -13.11 |
| 2025-02-03 | -13.06 |
| 2025-01-31 | -13.31 |
| 2025-01-30 | -13.34 |
| 2025-01-29 | -12.68 |
| 2025-01-28 | -12.68 |
| 2025-01-27 | -12.62 |
| 2025-01-24 | -12.70 |
| 2025-01-23 | -12.75 |
| 2025-01-22 | -12.68 |
| 2025-01-21 | -12.44 |
| 2025-01-17 | -12.48 |
| 2025-01-16 | -12.36 |
| 2025-01-15 | -12.38 |
| 2025-01-14 | -12.34 |
| 2025-01-13 | -13.19 |
| 2025-01-10 | -12.94 |
| 2025-01-08 | -13.76 |
| 2025-01-07 | -13.73 |
| 2025-01-06 | -13.58 |
| 2025-01-03 | -13.67 |
| 2025-01-02 | -13.63 |
| 2024-12-31 | -13.55 |
| 2024-12-30 | -13.37 |
| 2024-12-27 | -13.70 |
| 2024-12-26 | -14.03 |
| 2024-12-24 | -13.75 |